Pelashield™ PainGuard™ vs Restrata® in HS Surgery
Recruiting
N/A
Interventional Study
Hidradenitis Suppurativa (HS)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 10 (estimated)
- Sponsor
- Rutgers, The State University of New Jersey · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Hidradenitis Suppurativa (HS) is a long-lasting skin condition that causes painful lumps and infections. In severe cases, patients need surgery to remove the affected skin. After surgery, a wound dressing called a wound matrix is placed over the area to help the skin heal.
This study will compare two different wound matrices:
Restrata®, which is the current standard treatment. Pelashield™ PainGu…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults (≥18 years) with a confirmed clinical diagnosis of HS requiring wide surgical excision.
* Ability to provide informed consent in English.
* Willingness and ability to attend routine postoperative follow-up visits to monitor healing and readiness for second-stage closure…
Contacts